Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · IEX Real-Time Price · USD
1.790
-0.010 (-0.56%)
At close: Mar 28, 2024, 4:00 PM
1.752
-0.038 (-2.12%)
After-hours: Mar 28, 2024, 6:14 PM EDT

Milestone Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019
Market Capitalization
9656136196200392
Market Cap Growth
--58.82%-30.61%-2.08%-49.04%-
Enterprise Value
8142748258273
PE Ratio
-0.94-0.94-2.33-4.57-4.00-7.10
PS Ratio
95.6755.9227.1613.04--
PB Ratio
5.703.332.051.741.403.41
P/FCF Ratio
-1.20-1.20-2.57-5.89-3.94-7.60
P/OCF Ratio
-1.20-1.20-2.59-5.89-3.94-7.67
EV/Sales Ratio
81.4441.6914.745.48--
EV/EBITDA Ratio
-0.73-0.73-1.26-1.92-1.17-4.94
EV/EBIT Ratio
-0.73-0.73-1.26-1.92-1.17-4.94
EV/FCF Ratio
-0.90-0.90-1.40-2.47-1.15-5.29
Debt / Equity Ratio
3.093.090.040.010.010.00
Debt / EBITDA Ratio
-0.91-0.91-0.04-0.02-0.02-0.01
Debt / FCF Ratio
-1.11-1.11-0.05-0.02-0.02-0.01
Quick Ratio
9.589.5810.6616.8723.1414.42
Current Ratio
10.1110.1111.7017.5524.1414.71
Asset Turnover
0.010.010.060.1100
Interest Coverage
-22.37-22.37----
Return on Equity (ROE)
-171.00%-171.00%-70.60%-33.50%-46.20%-67.40%
Return on Assets (ROA)
-64.40%-64.40%-65.40%-31.90%-43.70%-44.70%
Return on Capital (ROIC)
-89.13%-89.13%-86.64%-38.02%-35.20%-50.14%
Earnings Yield
-62.39%-106.74%-43.00%-21.90%-25.01%-14.08%
FCF Yield
-48.64%-83.22%-38.85%-16.98%-25.39%-13.15%
Buyback Yield / Dilution
-1.19%-1.19%-1.47%-42.56%-85.91%-4845.07%
Total Shareholder Return
-1.19%-1.19%-1.47%-42.56%-85.91%-4845.07%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).